We know there has been a lot of recent news about Zantac®. At Sanofi, patient safety and the quality of our products are our top priority and are taken extremely seriously. Due to inconsistencies in preliminary test results of the active ingredient used in Zantac® products, Sanofi has made the decision to conduct a voluntary recall in the U.S. and Canada as the investigation continues.
We are committed to being transparent and will provide updates as information becomes available. Please continue to visit this page for updates. You may find information on general issue-related questions here. If you have any additional questions about Zantac®, please consult your healthcare provider or pharmacist.